Publication details

Dimethyl fumarát (Tecfidera, enterosolventní tvrdé tobolky) v léčbě relabující roztroušené sklerózy mozkomíšní – klinická účinnost a bezpečnostní profil

Title in English Dimethylfumarate in the treatment of relapsing multiple sclerosis – clinical efficacy and safety
Authors

ŠTOURAČ Pavel

Year of publication 2017
Type Popularization text
MU Faculty or unit

Faculty of Medicine

Citation
Description Dimethylfumarate is an efficient medicine in therapy of relapsing-remitting multiple sclerosis. It has significant clinical efficiency and good safety profile. Along with fingolimod, it belongs to the first and half line line therapy to which the patients may be escalated if the first-line therapy fails. Its advantages include monitoring of its efficacy and safety during the therapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info